# Focal Point Pharmaceuticals, Inc. — Form D

Focal Point Pharmaceuticals, Inc. of MEMPHIS, TN, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-14. The offering totals $150K, of which $150K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-08-14
- Form: D
- Accession: 0001584237-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $150K
- Amount sold: $150K
- Investors: 2
- Date of first sale: 2013-08-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-201309

## Issuer

- Name: Focal Point Pharmaceuticals, Inc.
- CIK: 0001584237
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 40 S. MAIN ST., MEMPHIS, TN, 38103
- Phone: 484-680-5222

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Gary Stevenson | Director | Chicago, IL |
| Gary Prosterman | Director | Memphis, TN |
| Gary Prosterman | Executive Officer | Memphis, TN |
| Raymond Hage | Director | Memphis, TN |
| Raymond Hage | Executive Officer | Memphis, TN |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-01-31](https://search.stillhousedata.com/formd/0001584237-17-000001) | D | $80K | $80K |
| [2017-01-31](https://search.stillhousedata.com/formd/0001584237-17-000002) | D/A | $80K | $80K |

## More

- [CIK 1584237 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1584237&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001584237-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.